NO871312L - Transdermalt dosimeter. - Google Patents
Transdermalt dosimeter.Info
- Publication number
- NO871312L NO871312L NO87871312A NO871312A NO871312L NO 871312 L NO871312 L NO 871312L NO 87871312 A NO87871312 A NO 87871312A NO 871312 A NO871312 A NO 871312A NO 871312 L NO871312 L NO 871312L
- Authority
- NO
- Norway
- Prior art keywords
- liquid phase
- phase
- contact bridge
- dosimeter
- treatment component
- Prior art date
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 29
- 230000002500 effect on skin Effects 0.000 claims description 23
- 239000007791 liquid phase Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 21
- 238000011282 treatment Methods 0.000 claims description 21
- 239000000853 adhesive Substances 0.000 claims description 18
- 230000001070 adhesive effect Effects 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000002250 absorbent Substances 0.000 claims description 9
- 230000002745 absorbent Effects 0.000 claims description 9
- 239000011230 binding agent Substances 0.000 claims description 9
- 239000007790 solid phase Substances 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 8
- 239000002356 single layer Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 239000012071 phase Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- CKFGINPQOCXMAZ-UHFFFAOYSA-N methanediol Chemical compound OCO CKFGINPQOCXMAZ-UHFFFAOYSA-N 0.000 claims 2
- 238000006555 catalytic reaction Methods 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 235000019256 formaldehyde Nutrition 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 239000012266 salt solution Substances 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 32
- 239000010410 layer Substances 0.000 description 16
- 229960000278 theophylline Drugs 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 210000004243 sweat Anatomy 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 239000013043 chemical agent Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 208000029108 46,XY sex reversal 8 Diseases 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000006538 anaerobic glycolysis Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- QTWZICCBKBYHDM-UHFFFAOYSA-N leucomethylene blue Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3NC2=C1 QTWZICCBKBYHDM-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229960000988 nystatin Drugs 0.000 description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- TWADJGWUKGOPFG-UHFFFAOYSA-N 2-methoxy-5-methyl-1,3-diphenylbenzene Chemical compound COC1=C(C=2C=CC=CC=2)C=C(C)C=C1C1=CC=CC=C1 TWADJGWUKGOPFG-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920006266 Vinyl film Polymers 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000009388 chemical precipitation Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 231100000317 environmental toxin Toxicity 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/0064—Devices for taking samples of body liquids for taking sweat or sebum samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4261—Evaluating exocrine secretion production
- A61B5/4266—Evaluating exocrine secretion production sweat secretion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4881—Determining interstitial fluid distribution or content within body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0009—Testing for drug or alcohol abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Dermatology (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Photoreceptors In Electrophotography (AREA)
- Laser Surgery Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/632,127 US4595011A (en) | 1984-07-18 | 1984-07-18 | Transdermal dosimeter and method of use |
| PCT/US1985/001436 WO1987000744A1 (en) | 1984-07-18 | 1985-07-31 | A transdermal dosimeter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO871312L true NO871312L (no) | 1987-03-27 |
| NO871312D0 NO871312D0 (no) | 1987-03-27 |
Family
ID=24534186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO1987871312A NO871312D0 (no) | 1984-07-18 | 1987-03-27 | Transdermalt dosimeter. |
Country Status (8)
Families Citing this family (150)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8404895L (sv) * | 1984-10-01 | 1986-03-17 | Torkel Ingemar Fischer | Medel for en overkenslighetstest |
| DE3503234C1 (de) * | 1985-01-31 | 1986-04-03 | Drägerwerk AG, 2400 Lübeck | Kolorimetrisches Gasdiffusions-Prüfröhrchen |
| US4706676A (en) * | 1985-02-11 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Dermal substance collection device |
| US4909256A (en) * | 1985-02-11 | 1990-03-20 | The United States Of America, As Represented By The Secretary Of The Army | Transdermal vapor collection method and apparatus |
| KR900005223B1 (ko) * | 1986-12-11 | 1990-07-21 | 가부시끼가이샤 호리바 세이사꾸쇼 | 이온농도등의 측정방법과 그 측정에 사용하는 계측기의 교정용시이트 및 교정방법 |
| US4817632A (en) * | 1987-06-23 | 1989-04-04 | Bioquant, Inc. | Oral fluid collection article |
| US4821733A (en) * | 1987-08-18 | 1989-04-18 | Dermal Systems International | Transdermal detection system |
| US5362307A (en) * | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
| KR970011449B1 (ko) * | 1988-01-29 | 1997-07-11 | 더 리전트 오브 디 유니버시티 오브 캘리포니아 | 이온전기 영동형 비침입 검체 채취 또는 이송 장치 및 방법 |
| US4957108A (en) * | 1988-09-08 | 1990-09-18 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
| US5441048A (en) * | 1988-09-08 | 1995-08-15 | Sudor Partners | Method and apparatus for determination of chemical species in perspiration |
| US5445147A (en) * | 1988-09-08 | 1995-08-29 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
| US5076273A (en) * | 1988-09-08 | 1991-12-31 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
| US5203327A (en) * | 1988-09-08 | 1993-04-20 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
| US5465713A (en) * | 1988-09-08 | 1995-11-14 | Sudor Partners | Energy-assisted transdermal collection patch for accelerated analyte collection and method of use |
| US5438984A (en) * | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
| US5817012A (en) * | 1988-09-08 | 1998-10-06 | Sudormed, Inc. | Method of determining an analyte |
| JP2628078B2 (ja) * | 1988-11-09 | 1997-07-09 | 日東電工株式会社 | 臨床検査用組成物 |
| US4953552A (en) * | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
| DE3919946A1 (de) * | 1989-06-19 | 1991-01-17 | Brinkhaus H Gmbh Co Kg | Verfahren zur bestimmung der gebrauchsintensitaet von textilstuecken und vorrichtung zur durchfuehrung des verfahrens |
| US5144958A (en) * | 1989-06-28 | 1992-09-08 | Mobil Oil Corporation | Apparatus for conducting mammalian dermatological studies |
| US5036861A (en) * | 1990-01-11 | 1991-08-06 | Sembrowich Walter L | Method and apparatus for non-invasively monitoring plasma glucose levels |
| JPH04278450A (ja) | 1991-03-04 | 1992-10-05 | Adam Heller | バイオセンサー及び分析物を分析する方法 |
| US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| US5140986A (en) * | 1991-08-19 | 1992-08-25 | Colormetric Laboratories, Inc. | System, device and method for skin contamination detection |
| US6685682B1 (en) | 1993-03-22 | 2004-02-03 | 3M Innovative Properties Company | Carrier delivered dressing and method of manufacture |
| ES2150984T3 (es) * | 1993-03-22 | 2000-12-16 | Minnesota Mining & Mfg | Apositos suministrados a partir de una estructura de bastidor y metodo de fabricacion. |
| JPH09503924A (ja) * | 1993-07-16 | 1997-04-22 | シグナス，インコーポレイテッド | 非侵襲性グルコースモニター |
| US5443080A (en) * | 1993-12-22 | 1995-08-22 | Americate Transtech, Inc. | Integrated system for biological fluid constituent analysis |
| US5396901A (en) * | 1994-01-11 | 1995-03-14 | Phillips; Michael | Transdermal dosimeter device |
| US6041253A (en) * | 1995-12-18 | 2000-03-21 | Massachusetts Institute Of Technology | Effect of electric field and ultrasound for transdermal drug delivery |
| US5879367A (en) * | 1995-09-08 | 1999-03-09 | Integ, Inc. | Enhanced interstitial fluid collection |
| US5735273A (en) | 1995-09-12 | 1998-04-07 | Cygnus, Inc. | Chemical signal-impermeable mask |
| US6234990B1 (en) | 1996-06-28 | 2001-05-22 | Sontra Medical, Inc. | Ultrasound enhancement of transdermal transport |
| JP2000513608A (ja) * | 1996-07-02 | 2000-10-17 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 包装された医療用接着複合物 |
| USD410087S (en) | 1996-07-02 | 1999-05-18 | Dunshee Wayne K | Adhesive bandage |
| DE69809391T2 (de) | 1997-02-06 | 2003-07-10 | Therasense, Inc. | Kleinvolumiger sensor zur in-vitro bestimmung |
| GB9717306D0 (en) * | 1997-08-15 | 1997-10-22 | Aromascan Plc | Method and device for detecting a condition |
| US6503198B1 (en) * | 1997-09-11 | 2003-01-07 | Jack L. Aronowtiz | Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods |
| US8287483B2 (en) * | 1998-01-08 | 2012-10-16 | Echo Therapeutics, Inc. | Method and apparatus for enhancement of transdermal transport |
| US20060015058A1 (en) * | 1998-01-08 | 2006-01-19 | Kellogg Scott C | Agents and methods for enhancement of transdermal transport |
| US7066884B2 (en) | 1998-01-08 | 2006-06-27 | Sontra Medical, Inc. | System, method, and device for non-invasive body fluid sampling and analysis |
| US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
| US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
| USD408541S (en) * | 1998-04-13 | 1999-04-20 | Dunshee Wayne K | Bandage and bandage with carrier |
| USD409754S (en) * | 1998-04-13 | 1999-05-11 | Dunshee Wayne K | Bandage |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
| US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| US6120464A (en) * | 1998-10-16 | 2000-09-19 | Integ, Inc. | Needle assembly for fluid sampler |
| US6475514B1 (en) * | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
| US20040171980A1 (en) | 1998-12-18 | 2004-09-02 | Sontra Medical, Inc. | Method and apparatus for enhancement of transdermal transport |
| EP1192269A2 (en) | 1999-06-18 | 2002-04-03 | Therasense, Inc. | MASS TRANSPORT LIMITED i IN VIVO /i ANALYTE SENSOR |
| US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
| US6831205B2 (en) * | 1999-11-29 | 2004-12-14 | Clozex Medical, Llc | Bandage for wound or incision closure |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| US6494833B1 (en) | 2001-06-19 | 2002-12-17 | Welch Allyn, Inc. | Conditioning apparatus for a chemical sensing instrument |
| US20030069482A1 (en) * | 2001-10-09 | 2003-04-10 | Workman Jerome James | Sampling article for determining quantitative and qualitative drug transfer to skin |
| EP1468281A1 (en) * | 2001-12-17 | 2004-10-20 | Powderject Research Limited | Diagnostic sensing apparatus |
| US7020508B2 (en) * | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
| US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
| EP1560931B1 (en) * | 2002-11-14 | 2011-07-27 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
| US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
| US20050021081A1 (en) * | 2003-07-24 | 2005-01-27 | Clozex Medical, Llc | Device for laceration or incision closure |
| US8636763B2 (en) * | 2003-07-24 | 2014-01-28 | Clozex Medical, Llc | Device for laceration or incision closure |
| US7414168B2 (en) * | 2003-07-24 | 2008-08-19 | Clozex Medical Llc | Device for laceration or incision closure |
| US7354446B2 (en) * | 2003-07-24 | 2008-04-08 | Clozex Medical, Llc | Device for laceration or incision closure |
| US7838718B2 (en) * | 2003-07-24 | 2010-11-23 | Clozex Medical, Llc | Device for laceration or incision closure |
| USD495419S1 (en) | 2003-08-15 | 2004-08-31 | 3M Innovative Properties Company | Bandage |
| US7332641B2 (en) * | 2003-10-10 | 2008-02-19 | Clozex Medical Llc | Interlaced compositions and methods of production |
| USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
| EP1718198A4 (en) | 2004-02-17 | 2008-06-04 | Therasense Inc | METHOD AND SYSTEM FOR PROVIDING DATA COMMUNICATION IN A CONTINUOUS BLOOD SUGAR MONITORING AND MANAGEMENT SYSTEM |
| US20160192880A9 (en) * | 2004-05-28 | 2016-07-07 | David Scott Utley | Intra-Oral Detector and System for Modification of Undesired Behaviors and Methods Thereof |
| ATE534750T1 (de) | 2004-07-30 | 2011-12-15 | Adeza Biomedical Corp | Onkofetales fibronektin als zervixkarzinom-marker |
| DE102004039570B4 (de) * | 2004-08-14 | 2007-03-01 | Lts Lohmann Therapie-Systeme Ag | Überwachungssystem zum Sammeln und zur transdermalen Weiterdiffusion von Umweltkontaminantien enthaltender Luft und Verfahren hierzu |
| US7563941B2 (en) | 2004-09-10 | 2009-07-21 | Clozex Medical, Llc | Modular wound dressing system |
| US20060094944A1 (en) * | 2004-10-28 | 2006-05-04 | Sontra Medical Corporation | System and method for analyte sampling and analysis with error correction |
| US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
| US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
| US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
| US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
| US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
| US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
| US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
| US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
| US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
| US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US8084268B2 (en) * | 2005-02-25 | 2011-12-27 | L'oreal | Method of evaluating the potential of the skin for scavenging free radicals |
| FR2882595B1 (fr) * | 2005-02-25 | 2007-05-25 | Oreal | Procede pour evaluer le potentiel de desactivation de radicaux libres de la peau |
| US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
| US8105353B2 (en) | 2005-08-09 | 2012-01-31 | Clozex Medical, Llc | Wound closure kit and method of using the same |
| US20070038246A1 (en) * | 2005-08-09 | 2007-02-15 | Clozex Medical, Llc | Four component wound closure device with locking strip |
| US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
| US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
| US7432069B2 (en) * | 2005-12-05 | 2008-10-07 | Sontra Medical Corporation | Biocompatible chemically crosslinked hydrogels for glucose sensing |
| WO2007120363A2 (en) | 2005-12-28 | 2007-10-25 | Abbott Diabetes Care, Inc. | Medical device insertion |
| US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
| US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
| US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
| US20080071157A1 (en) | 2006-06-07 | 2008-03-20 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
| USD611156S1 (en) | 2006-06-12 | 2010-03-02 | 3M Innovative Properties Company | Bandage |
| US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
| US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
| US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
| EP2124723A1 (en) * | 2007-03-07 | 2009-12-02 | Echo Therapeutics, Inc. | Transdermal analyte monitoring systems and methods for analyte detection |
| FR2913600B1 (fr) * | 2007-03-13 | 2011-02-25 | Dbv Tech | Dispositif pour l'application cutanee de substances. |
| PL2152358T3 (pl) | 2007-04-27 | 2011-09-30 | Echo Therapeutics Inc | Urządzenie do realizacji permeacji skórnej dla pomiaru analitów i przezskórnego podawania leku |
| US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
| WO2008150917A1 (en) | 2007-05-31 | 2008-12-11 | Abbott Diabetes Care, Inc. | Insertion devices and methods |
| US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
| US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
| US20100213057A1 (en) | 2009-02-26 | 2010-08-26 | Benjamin Feldman | Self-Powered Analyte Sensor |
| US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
| US9184490B2 (en) | 2009-05-29 | 2015-11-10 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
| WO2011026148A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
| EP3001194B1 (en) | 2009-08-31 | 2019-04-17 | Abbott Diabetes Care, Inc. | Medical devices and methods |
| EP2473098A4 (en) | 2009-08-31 | 2014-04-09 | Abbott Diabetes Care Inc | ANALYTICAL SIGNAL PROCESSING APPARATUS AND METHOD |
| EP2482720A4 (en) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | METHOD AND APPARATUS FOR PROVIDING NOTIFICATION FUNCTION IN SUBSTANCE MONITORING SYSTEMS |
| WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
| USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
| EP2552532A1 (en) | 2010-03-24 | 2013-02-06 | Abbott Diabetes Care, Inc. | Medical device inserters and processes of inserting and using medical devices |
| GB201008448D0 (en) | 2010-05-20 | 2010-07-07 | Univ Strathclyde | Transdermal device |
| US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
| JP6443802B2 (ja) | 2011-11-07 | 2018-12-26 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | 分析物モニタリング装置および方法 |
| LT3831283T (lt) | 2011-12-11 | 2023-08-10 | Abbott Diabetes Care, Inc. | Analitės jutiklio įrenginiai, sujungimai ir būdai |
| US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
| AU2016260547B2 (en) | 2015-05-14 | 2020-09-03 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| CA3050721A1 (en) | 2017-01-23 | 2018-07-26 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
| US20200397416A1 (en) * | 2018-02-22 | 2020-12-24 | The Regents Of The University Of Michigan | Liquid activated devices and systems |
| USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
| USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3216411A (en) * | 1962-05-16 | 1965-11-09 | Nippon Electric Co | Ingestible transmitter for the detection of bleeding in the gastrointestinal canal |
| US3289671A (en) * | 1963-09-11 | 1966-12-06 | Troutman Edwin Glenn | Iontophoresis method |
| US3552929A (en) * | 1968-01-23 | 1971-01-05 | Minnesota Mining & Mfg | Diagnosis means |
| US3903423A (en) * | 1974-05-09 | 1975-09-02 | American Cyanamid Co | Sunburn dosimeter |
| JPS5912135B2 (ja) * | 1977-09-28 | 1984-03-21 | 松下電器産業株式会社 | 酵素電極 |
| SE7811708L (sv) * | 1977-11-15 | 1979-05-16 | Medishield Corp Ltd | Transkutan sond |
| US4190060A (en) * | 1978-04-19 | 1980-02-26 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Sweat collection capsule |
| US4329999A (en) * | 1980-03-03 | 1982-05-18 | Michael Phillips | Patient attached patch and method of making |
| US4472507A (en) * | 1981-06-04 | 1984-09-18 | Pluim Jr Arthur W | Method for detecting exposure to poison ivy and the like |
| US4444193A (en) * | 1982-01-11 | 1984-04-24 | Medtronic, Inc. | Fluid absorbent quantitative test device |
| US4454007A (en) * | 1983-01-27 | 1984-06-12 | E. I. Du Pont De Nemours And Company | Ion-selective layered sensor and methods of making and using the same |
-
0
- DK DK8601218D patent/DK8601218A/da unknown
-
1984
- 1984-07-18 US US06/632,127 patent/US4595011A/en not_active Expired - Fee Related
-
1985
- 1985-07-31 JP JP60503426A patent/JPS63500427A/ja active Pending
- 1985-07-31 AU AU46400/85A patent/AU581916B2/en not_active Expired - Fee Related
- 1985-07-31 EP EP85903945A patent/EP0231172A1/en not_active Withdrawn
- 1985-07-31 WO PCT/US1985/001436 patent/WO1987000744A1/en not_active Application Discontinuation
- 1985-07-31 BR BR8506875A patent/BR8506875A/pt unknown
-
1986
- 1986-03-17 DK DK121886A patent/DK121886D0/da not_active Application Discontinuation
-
1987
- 1987-03-27 NO NO1987871312A patent/NO871312D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR8506875A (pt) | 1987-10-27 |
| DK121886A (da) | 1986-03-17 |
| DK121886D0 (da) | 1986-03-17 |
| JPS63500427A (ja) | 1988-02-18 |
| AU581916B2 (en) | 1989-03-09 |
| DK8601218A (US20100170793A1-20100708-C00006.png) | 1986-03-17 |
| WO1987000744A1 (en) | 1987-02-12 |
| US4595011A (en) | 1986-06-17 |
| AU4640085A (en) | 1987-03-05 |
| NO871312D0 (no) | 1987-03-27 |
| EP0231172A1 (en) | 1987-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO871312L (no) | Transdermalt dosimeter. | |
| US4732153A (en) | Transdermal dosimeter | |
| Sharma et al. | Transdermal drug delivery system: a review | |
| US5271940A (en) | Transdermal delivery device having delayed onset | |
| Arunachalam et al. | Transdermal drug delivery system: a review | |
| US5139023A (en) | Apparatus and method for noninvasive blood glucose monitoring | |
| US6251083B1 (en) | Interstitial fluid methods and devices for determination of an analyte in the body | |
| JPS63500396A (ja) | 皮膚物質採集装置 | |
| US4909256A (en) | Transdermal vapor collection method and apparatus | |
| AU760588B2 (en) | Pressure sensitive adhesive matrix patch for the treatment of onychomycosis | |
| Barr | Percutaneous absorption | |
| DK153204B (da) | Middel til udfoerelse af overfoelsomhedstests | |
| WO2000014535A9 (en) | Interstitial fluid methods and devices for determination of an analyte in the body | |
| Lewis et al. | Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation | |
| CA2602534C (en) | Transdermal patch | |
| US5396901A (en) | Transdermal dosimeter device | |
| EP0491853A1 (en) | Transdermal delivery device having delayed onset | |
| EP0384267B1 (de) | Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen | |
| KR20000071157A (ko) | 향상된 물리적 특성의 폴리아크릴레이트 매트릭스로 된 경피형또는 국부형 플래스터 시스템 | |
| Skopp et al. | Preliminary practical findings on drug monitoring by a transcutaneous collection device | |
| JP3285451B2 (ja) | 全血試料の分析方法および分析要素 | |
| Savoji et al. | Transdermal nitroglycerin delivery using acrylic matrices: design, formulation, and in vitro characterization | |
| Hadgraft | Pharmaceutical aspects of transdermal nitroglycerin | |
| Prodduturi et al. | Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation | |
| WO1990015568A2 (en) | Apparatus and methods for noninvasive blood glucose monitoring |